Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding GB:BIOT?
Track your performance easily
GB:BIOT Price & Analysis
BIOT ETF Chart & Stats
Day’s Range― - ―
52-Week Range$9.04 - $11.26
Previous Close$10.9
VolumeN/A
Average Volume (3M)2.63K
AUM18.44M
NAV10.86
Expense Ratio0.49%
Holdings Count43
Beta0.77
Inception DateJan 23, 2018
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.05
10 Day Avg. Volume128
30 Day Avg. Volume2,632
Alpha0.00242
L&G Pharma Breakthrough UCITS ETF (BIOT) Fund Flow Chart
L&G Pharma Breakthrough UCITS ETF (BIOT) 1 year Net Flows: -$28M
BIOT ETF News
BIOT ETF FAQ
What was GB:BIOT’s price range in the past 12 months?
GB:BIOT lowest ETF price was $9.04 and its highest was $11.26 in the past 12 months.
What is the AUM of GB:BIOT?
As of Sep 19, 2024 The AUM of GB:BIOT is 18.44M.
Is GB:BIOT overvalued?
According to Wall Street analysts GB:BIOT’s price is currently Undervalued.
Does GB:BIOT pay dividends?
GB:BIOT does not currently pay dividends.
How many shares outstanding does GB:BIOT have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:BIOT?
Currently, no hedge funds are holding shares in GB:BIOT
Top 10 Holdings
Alnylam Pharmaceuticals
4.00%
Bavarian Nordic AS
3.59%
Pharma Mar SA
3.52%
United Therapeutics Corp.
3.35%
BioCryst Pharmaceuticals
3.20%
Halozyme Therapeutics
3.20%
Swedish Orphan Biovitrum Ab
2.78%
AstraZeneca
2.70%
BeiGene, Ltd.
2.66%
Chugai Pharmaceutical Co
2.57%
Total31.57%
ETF Description
L&G Pharma Breakthrough UCITS ETF
The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.